NCT04618393 A Study of EMB-02 in Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT04601285 A Phase I Study of JS108 in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT04577703 First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04565275 A Study of ICP-192 in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT04518137 A Study of Evaluating the Safety and Efficacy of ATG-008 for Advanced Solid Tumors (BUNCH) Status TERMINATED Phase PHASE2
NCT04492488 A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04487236 Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04481009 A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04471675 Evaluation of the Safety and Efficacy of Albumin-bound Docetaxel Status UNKNOWN Phase PHASE1
NCT04450901 Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT04449874 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04446260 A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors Status COMPLETED Phase PHASE1
NCT04408079 A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3558 Tablets Status UNKNOWN Phase PHASE1
NCT04393298 A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04362748 Study of AMG 256 in Adult Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04335604 A Study of NOV140201 (JPI-547) in Subject With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04312282 The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT04309968 Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1